{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:42:55Z","timestamp":1789954975224,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T00:00:00Z","timestamp":1450483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10549-015-3662-2","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T06:25:02Z","timestamp":1450506302000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Screening for germline mutations in breast\/ovarian cancer susceptibility genes in high-risk families in Israel"],"prefix":"10.1007","volume":"155","author":[{"given":"Tamar","family":"Yablonski-Peretz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Paluch-Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior Soussan","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addie","family":"Dvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Barnes-Kedar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Kadouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriya","family":"Semenisty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Efrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Neiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafit","family":"Glasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Michaelson-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Golan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Reish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayala","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Safra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Yaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,19]]},"reference":[{"key":"3662_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","volume":"12","author":"N Petrucelli","year":"2010","unstructured":"Petrucelli N, Daly MB, Feldman GL (2010) Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genet Med 12:245\u2013259","journal-title":"Genet Med"},{"key":"3662_CR2","first-page":"505","volume":"60","author":"D Abeliovich","year":"1997","unstructured":"Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T (1997) The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505\u2013514","journal-title":"Am J Hum Genet"},{"key":"3662_CR3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/gyno.2000.5848","volume":"78","author":"DH Tobias","year":"2000","unstructured":"Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ (2000) Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. Gynecol Oncol 78:148\u2013151","journal-title":"Gynecol Oncol"},{"key":"3662_CR4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","volume":"91","author":"E Warner","year":"1999","unstructured":"Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241\u20131247","journal-title":"J Natl Cancer Inst"},{"key":"3662_CR5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/302320","volume":"64","author":"P Hartge","year":"1999","unstructured":"Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64:963\u2013970","journal-title":"Am J Hum Genet"},{"key":"3662_CR6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jmg.39.8.611","volume":"39","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Perez-Segura P, Robson ME, Scheuer L, Siegel B, Schluger A, Rapaport B, Frank TS, Nafa K, Ellis NA, Parmigiani G, Offit K (2002) Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families. J Med Genet 39:611\u2013614","journal-title":"J Med Genet"},{"key":"3662_CR7","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1158\/0008-5472.CAN-08-0599","volume":"68","author":"MD Palma","year":"2008","unstructured":"Palma MD, Domchek SM, Stopfer J, Erlichman J, Siegfried JD, Tigges-Cardwell J, Mason BA, Rebbeck TR, Nathanson KL (2008) The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. Cancer Res 68:7006\u20137014","journal-title":"Cancer Res"},{"key":"3662_CR8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000051156","volume":"4","author":"R Shiri-Sverdlov","year":"2001","unstructured":"Shiri-Sverdlov R, Gershoni-Baruch R, Ichezkel-Hirsch G, Gotlieb WH, Bruchim Bar-Sade R, Chetrit A, Rizel S, Modan B, Friedman E (2001) The Tyr978X BRCA1 mutation in non-Ashkenazi Jews: occurrence in high-risk families, general population and unselected ovarian cancer patients. Community Genet 4:50\u201355","journal-title":"Community Genet"},{"key":"3662_CR9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1086\/301924","volume":"63","author":"I Lerer","year":"1998","unstructured":"Lerer I, Wang T, Peretz T, Sagi M, Kaduri L, Orr-Urtreger A, Stadler J, Gutman H, Abeliovich D (1998) The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. Am J Hum Genet 63:272\u2013274","journal-title":"Am J Hum Genet"},{"key":"3662_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/cge.12256","volume":"84","author":"FS Hilbers","year":"2013","unstructured":"Hilbers FS, Vreeswijk MP, van Asperen CJ, Devilee P (2013) The impact of next generation sequencing on the analysis of\u00a0breast cancer\u00a0susceptibility: a role for extremely rare genetic variation? Clin Genet 84:407\u2013414","journal-title":"Clin Genet"},{"key":"3662_CR11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10689-012-9540-8","volume":"11","author":"I Catucci","year":"2012","unstructured":"Catucci I, Milgrom R, Kushnir A, Laitman Y, Paluch-Shimon S, Volorio S, Ficarazzi F, Bernard L, Radice P, Friedman E, Peterlongo P (2012) Germline mutations in BRIP1 and\u00a0PALB2\u00a0in Jewish high cancer risk families. Fam Cancer 11:483\u2013491","journal-title":"Fam Cancer"},{"key":"3662_CR12","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10549-012-2317-9","volume":"136","author":"A Kushnir","year":"2012","unstructured":"Kushnir A, Laitman Y, Shimon SP, Berger R, Friedman E (2012) Germline mutations in\u00a0RAD51C\u00a0in Jewish high cancer risk families. Breast Cancer Res Treat 136:869\u2013874","journal-title":"Breast Cancer Res Treat"},{"key":"3662_CR13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1034\/j.1399-0004.2002.620407.x","volume":"62","author":"A Figer","year":"2002","unstructured":"Figer A, Kaplan A, Frydman M, Lev D, Paswell J, Papa MZ, Goldman B, Friedman E (2002) Germline mutations in the\u00a0PTEN\u00a0gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer. Clin Genet 62:298\u2013302","journal-title":"Clin Genet"},{"key":"3662_CR14","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","volume":"32","author":"AW Kurian","year":"2014","unstructured":"Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whittemore AS, McGuire V, Ladabaum U, Kobayashi Y, Lincoln SE, Cargill M, Ford JM (2014) Clinical evaluation of a multiple-gene sequencing panel for hereditary\u00a0cancer\u00a0risk assessment. J Clin Oncol 32:2001\u20132009","journal-title":"J Clin Oncol"},{"key":"3662_CR15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","volume":"17","author":"SE Lincoln","year":"2015","unstructured":"Lincoln SE, Kobayashi Y, Anderson MJ, Yang S, Desmond AJ, Mills MA, Nilsen GB, Jacobs KB, Monzon FA, Kurian AW, Ford JM, Ellisen LW (2015) A Systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients. J Mol Diagn 17:533\u2013544","journal-title":"J Mol Diagn"},{"key":"3662_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-4608(98)00165-4","volume":"109","author":"HT Lynch","year":"1999","unstructured":"Lynch HT, Watson P, Tinley S, Snyder C, Durham C, Lynch J, Kirnarsky Y, Serova O, Lenoir G, Lerman C, Narod SA (1999) An update on DNA-based BRCA1\/BRCA2 genetic counseling in hereditary breast cancer. Cancer Genet Cytogenet 109:91\u201398","journal-title":"Cancer Genet Cytogenet"},{"key":"3662_CR17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O\u2019Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG, College American, American College of Medical Genetics and Genomics (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15:565\u2013574","journal-title":"Genet Med"},{"key":"3662_CR18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ajhg.2009.08.018","volume":"85","author":"SV Tavtigian","year":"2009","unstructured":"Tavtigian SV, Oefner PJ, Babikyan D et al (2009) Rare, evolutionarily unlikely missense substitutions in\u00a0ATM\u00a0confer increased risk of breast cancer. Am J Hum Genet 85:427\u2013446","journal-title":"Am J Hum Genet"},{"key":"3662_CR19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1470-2045(11)70076-6","volume":"12","author":"B Zhang","year":"2011","unstructured":"Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011) Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol 12:477\u2013488","journal-title":"Lancet Oncol"},{"key":"3662_CR20","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1007\/s11033-011-1381-2","volume":"39","author":"L Shen","year":"2012","unstructured":"Shen L, Yin ZH, Wan Y, Zhang Y, Li K, Zhou BS (2012) Association between ATM polymorphisms and cancer risk: a meta-analysis. Mol Biol Rep 39:5719\u20135725","journal-title":"Mol Biol Rep"},{"key":"3662_CR21","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10549-012-2006-8","volume":"133","author":"Y Laitman","year":"2012","unstructured":"Laitman Y, Simeonov M, Herskovitz L, Kushnir A, Shimon-Paluch S, Kaufman B, Zidan J, Friedman E (2012) Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel. Breast Cancer Res Treat 133:1153\u20131157","journal-title":"Breast Cancer Res Treat"},{"key":"3662_CR22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10549-010-1217-0","volume":"127","author":"Y Laitman","year":"2011","unstructured":"Laitman Y, Borsthein RT, Stoppa-Lyonnet D, Dagan E, Castera L, Goislard M, Gershoni-Baruch R, Goldberg H, Kaufman B, Ben-Baruch N, Zidan J, Maray T, Soussan-Gutman L, Friedman E (2011) Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel. Breast Cancer Res Treat 127:489\u2013495","journal-title":"Breast Cancer Res Treat"},{"key":"3662_CR23","doi-asserted-by":"crossref","unstructured":"Rosenthal E, Moyes K, Arnell C, Evans B, Wenstrup RJ (2015) Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry. Breast Cancer Res Treat 149:223\u2013227. Erratum in: Breast Cancer Res Treat (2015) 151:233","DOI":"10.1007\/s10549-014-3218-x"},{"key":"3662_CR24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10897-014-9762-z","volume":"24","author":"N Petrucelli","year":"2015","unstructured":"Petrucelli N, Mange S, Fulbright JL, Dohany L, Zakalik D, Duquette D (2015) To reflex or not: additional BRCA1\/2 testing in Ashkenazi Jewish individuals without founder mutations. J Genet Couns 24:285\u2013293","journal-title":"J Genet Couns"},{"key":"3662_CR25","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1093\/hmg\/ddr229","volume":"20","author":"LM Pelttari","year":"2011","unstructured":"Pelttari LM, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K, Blomqvist C, Aittom\u00e4ki K, B\u00fctzow R, Nevanlinna H (2011) RAD51C is a susceptibility gene for ovarian cancer. Hum Mol Genet 20:3278\u20133288","journal-title":"Hum Mol Genet"},{"key":"3662_CR26","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/bcr2832","volume":"13","author":"KM Kuusisto","year":"2011","unstructured":"Kuusisto KM, Bebel A, Vihinen M, Schleutker J, Sallinen SL (2011) Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1\/2-founder mutation-negative breast and\/or ovarian cancer individuals. Breast Cancer Res 13:R20","journal-title":"Breast Cancer Res"},{"key":"3662_CR27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of\u00a0breast cancer. JAMA 295:1379\u20131388","journal-title":"JAMA"},{"key":"3662_CR28","author":"A Zick","year":"2015","unstructured":"Zick A, Cohen S, Hamburger T, Goldberg Y, Zvi N, Sagi M, Peretz T (2015) A BRCA1 frameshift mutation in women of Kurdish Jewish Descent. Open Breast Cancer J. doi: 10.2174\/1876817220150529E001","journal-title":"Open Breast Cancer J"},{"key":"3662_CR29","unstructured":"NCCN guidelines. Genetic\/familial high-risk assessment: Breast and ovarian. Version 2.2015. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf . Accessed 11 Nov 2015"},{"key":"3662_CR30","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","volume":"22","author":"L Cast\u00e9ra","year":"2014","unstructured":"Cast\u00e9ra L, Krieger S, Rousselin A, Legros A, Baumann JJ, Bruet O, Brault B, Fouillet R, Goardon N, Letac O, Baert-Desurmont S, Tinat J, Bera O, Dugast C, Berthet P, Polycarpe F, Layet V, Hardouin A, Fr\u00e9bourg T, Vaur D (2014) Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur J Hum Genet 22:1305\u20131313","journal-title":"Eur J Hum Genet"},{"key":"3662_CR31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, Timms K, Garber JE, Herold C, Ellisen L, Krejdovsky J, DeLeonardis K, Sedgwick K, Soltis K, Roa B, Wenstrup RJ, Hartman AR (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121:25\u201333","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3662-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3662-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3662-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:43:18Z","timestamp":1559234598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3662-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3662"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3662-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,19]]}}}